START Midwest Michigan, PC

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
1/2	A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies	Recruiting	Active	DCC-3116 + Ripretinib	NCT05957367
1	Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas	Recruiting	Active, not recruitiing	INBRX-109 + Temozolomide	NCT03715933